Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/33609

Title:	Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?
Authors:	İnanç, Nevsun Özen, Gülşen Yalçınkaya, Yasemin Koca, Süleyman Serdar Can, Gerçek Karataş, Ahmet Yazıcı, Ayten Cefle, Ayşe Tufan, Abdurrahman Akar, Servet Şenel, Soner Öz, Burak Akkoç, Nurullah Önen, Fatoş Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı. Dalkılıç, Ediz Pehlivan, Yavuz CMF-4757-2022 AAG-8227-2021
Keywords:	Rheumatology
Issue Date:	Oct-2017
Publisher:	Wiley
Citation:	İnanç, N. vd. (2017). ''Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?''. Arthritis & Rheumatology, 69(Supplement 10).
URI:	https://acrjournals.onlinelibrary.wiley.com/loi/23265205 http://hdl.handle.net/11452/33609
ISBN:	2326-5205
ISSN:	2326-5191
Appears in Collections:	Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI